Study Group: Medical Device Experts(?)
Council Members in this Study Group: 257
Request a survey with this Study Group
Leading Experts in this Study Group
 |
What is a GLG Leader? |
Patrick Joseph IgoeLife Sciences Patent Attorney
Independent IP Litigation Consultant
Patrick Joseph Igoe is a consultant and registered patent attorney in New York. His focus is patent issues throughout Life Sciences - for example, diagnostic/therapeutic assays; medical devices/imaging technologies; Rx antibiotics, biologics, drugs, and vaccines; and OTC medicines. His expertise includes...
Eric Gruff, PhD MBAPrincipal
E4 Consulting
Eric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 16 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...
Hany SalamaDirector, Global Manufacturing and Pharmaceutical
Barrier Therapeutics
Hany Salama, ME, MBA, CPM, is the Director of Global Manufacturing and Pharmaceuticals at Barrier Therapeutics, Inc., New Jersey. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible...
Volunteer Professor of Law
University of Cincinnati - CC
James O'Reilly is a Volunteer Professor of Law at University of Cincinnati, where he has counseled large and small drug, biotech, device and food firms since becoming a full time professor in 1998. Prof. O’Reilly’s 31 books and 137 articles have been widely cited, and as an FDA expert over many years...
Principal
Law Offices of Michael D. McNeely
Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...
Anthony Catanach, Jr.Director
DI2 Associates, LLC
Anthony H. Catanach Jr., PhD, is a Professor in the Strategic Initiatives Group of the Villanova University School of Business. He also is a Director at DI2 Associates, a Pennsylvania based accounting and reporting consulting firm. Dr. Catanach has expertise in the areas of business risk management...
Scot Bradley Glasberg, MDAttending Staff Physician
Lenox Hill Hospital
Scot Glasberg, MD, is a Cosmetic and Reconstructive Plastic Surgeon in private practice in New York. Dr. Glasberg is also an Attending Staff Physician at Lenox Hill and Manhattan Eye, Ear and Throat Hospitals. He holds numerous positions within national, regional, and local medical and specialty societies...
Martin GoldPrincipal
Technology Access Partners, LLC
Martin Gold, MBA, is the Founder and Principal of Technology Access Partners, LLC and eMedLearn, LLC in New York. He assists medical technology manufacturers and investors to assess and respond to the business and investment challenges related to reimbursement. Mr. Gold has experience in reimbursement,...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Experts(?)
Product liability exposure of new materials makers can be severe, especially with fatal consequences of failures Internal memos re product problems can shoot company in the foot; prudent firms have a plan for controlling open-ended speculative memos in an instant-message environment Major PR and govt....
First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial...
One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China. Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither...
It's easy to point fingers of blame and this article does that, very well. According to the "annalysis" everybody is to blame. And, they're right, everyone is to blame, but where the article fails is the authoris inability to point out a real solution to the problem of wasted dollars spent...
Over the last year, it has become clear that the over-use of anemia drugs for cancer and renal failure has become a problem. The reason can be sumed up in one word, which is profit.
GLG InstituteSM
Seminars with this Study Group's Leaders(?)
Recent Seminars
Webcasts
Most Common Company Types:
- Medical Device Manufacturer
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Consultancy, Healthcare-Focused
- Medical Device Consultancy
- Individual/Small Consultancy
- Academic Institution*
- Law Firm (general practice/large)
- Pharmaceuticals Manufacturer
- Consultancy, Pharma-Focused
- Strategic Management
Most Common Job Types:
- President
- Director
- Owner
- Principal
- Physician - Attending Physician
- Chief Executive Officer
- Partner
- Consultant
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms